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Fixed drug eruption(FDE) is a delayed drug hypersensitivity reactionthat rarely occurs in children. It typically appears as macules that are individual or in small number,erythematous, well-circumscribed,and oval causing intense pruritus, burning or pain. They are most frequentlylocatedon the lips, palms, soles, glans penis, and groin areas andusually resolve spontaneously after discontinuation of the culprit drug, leaving hyperpigmentation [1] . It is characteristic that theyreappear in the same skin site if reexposure to the drug occurs.The most frequent drugs that cause FDE are analgesics, antimalarials, barbiturates and antibiotics including amoxicillin [2, 3] . A diagnosis of FDE includesskin tests and drug challenge tests (DCT) (4). There are rare clinical variants of FDE that include: nonpigmenting FDE (NPFDE), generalized FDE and other atypical presentations.NPFDE is a very rare FDE variant,characterized bynot leavingany residual hyperpigmentation. There have been few cases of NPFDEdescribed in adults [2] and only twocases in children [5, 6] .We reporta case of skin desquamation and onycholysisNPFDE selectiveto amoxicillinconfirmed witha DCT. Since studies assessing cross-reactivity in delayed type reactions in beta-lactams are limited, we also evaluated cross-reactivity to other beta-lactams by performing a DCT.
The patient, a 17-year-old male with Down Syndrome and mild atopic dermatitis, presented 4 episodes of skin desquamation on the posterior part of his thumb and index finger of his right hand24-48 hours after finishing 7 days of oral amoxicillintreatment prescribedforinfections such as tonsillitis. The first episode happened at the age of 13 and reactions occurred once annually during the following 3 years after the intake of amoxicillin. In one of the 4 episodes, the extension of the reactionalso produced onycholysis in his rightindex finger that recovered spontaneously aftera few weeks. In all the episodes skin lesions disappeared in 6-7 days without leaving any residual lesion. The patient previously tolerated penicillin, amoxicillin and amoxicillin/clavulanicon several occasions.
Theallergological work-up was initiated by performingpatch tests on the upper part of the patient's back with amoxicillin, amoxicillin/clavulanic acid, penicillin and cefuroxime according to the European Society of Contact Dermatitisguidelines [7] . The patch tests concentrations in petrolatum were: amoxicillin 50%,amoxicillin/clavulanic acid 50% (amoxicillin/clavulanic 875/125 mg), penicillin 10% and cefuroxime 10%. All tests were negative at 48 and96 hours readings. Wealso performed the tests with amoxicillin on the lesion site,but theydetached shortly afterdue to the lack of adhesion on the fingers.
We performed a DCT with amoxicillin 750mgevery 8 hours for7 days. The first dose was administeredin our department at 60 minutes intervals (1/100, 1/10, followed by full dose) [4] and the patient remained under medical surveillance for 2 hours. The remaining doses were received at home. The patientpresented desquamation from the distal posterior part of his thumb and index finger (Figure 1 )2 days after finishing the final dose of amoxicillin. The lesions resolved spontaneously within 7 days, leaving no residual pigmentation.
Four months after the positive DCT with amoxicillin, we evaluated cross-reactivity to other beta-lactams with and without identical side chainsusing a DCT with penicillin G and cefadroxil. The patient tolerated 750mg of penicillin G in our department (reached with a gradual increase) followed by a dose of 750mg at home every 8 hours for 7 days. Two months later, a DCT was performed with cefadroxil up to a total dose of 500mgunder medical surveillance, which was negative. The next doses were administered at home every 12 hours, with the patient presenting stomach discomfort after the first two doses, resulting in discontinuation of the treatment, and inconclusive results for the evaluation of cefadroxil tolerance. Outside of the allergological study, the patient was also prescribed cefuroxime, a beta-lactam with different side chain, which was also tolerated. Therefore, the patient was diagnosedwithdesquamative NPFDE selective to amoxicillin.We forbade the administration of aminopenicillins and cephalosporins with the same side chain.
FDE has been suggested to be a form of classic delayed-type hypersensitivity mediated by CD8+ cells and it has been demonstrated that intraepidermal T cells expressing the receptor (TCR)-αβare abundantly detected between keratinocytes in the lesions of FDE (1) .NPFDE is a rare delayed drug reaction. Only two cases have been reportedin children: a13-year-oldteenager with palms and soles bullous desquamation NPFDE caused by amoxicillin and rifamycin [5] and a 10-year-old boy with penis swelling NPFDE caused by amoxicillin [6] .To our knowledge, there have been no reported cases of a selective desquamative type of NPFDE exclusively to amoxicillin,demonstrated by DCT, in a boy.
Whilebetter methods for diagnosing FDE are still being debated, a DCT is the most reliable for establishing the causative drug [1] . In this case, a positive amoxicillinDCTdiagnosed a patient with negative patch tests.The use of patch testshas been controversialdue to an elevated number of false negative resultsdue to different causes [1] .
While cross-reactivity between beta-lactams in immediate type-I reactions has been evaluated more extensively [8] , it has been investigated less in delayed non type-I reactions [9] . A reason for cross-reactivity may be that amoxicillin and some early generation cephalosporins share identical side chains such ascefadroxil, cefatrizine and cefprozil,or similar side chainssuch ascefamandole and cefonicid [10] . Further research is still needed to evaluate cross-reactivity in fixed drug reactions caused by betalactams.
By studying cross-reactivity,weproved the amino-selectivity of the reaction and provided the patient with safe alternatives of other beta-lactams.
